{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:03:58Z","timestamp":1792713838825,"version":"4.5.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002714","name":"University of Freiburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>In pure aortic regurgitation, transcatheter aortic valve replacement (TAVR) is not yet used on a regular base. Due to constant development of TAVR, it is necessary to analyze current data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>By use of health records, we analyzed all isolated TAVR or surgical aortic valve replacements (SAVR) for pure aortic regurgitation between 2018 and 2020 in Germany.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>4,861 procedures\u20144,025 SAVR and 836 TAVR\u2014for aortic regurgitation were identified. Patients treated with TAVR were older, showed a higher logistic EuroSCORE, and had more pre-existing diseases. While results indicate a slightly higher unadjusted in-hospital mortality for transapical TAVR (6.00%) vs. SAVR (5.71%), transfemoral TAVR showed better outcomes, with self-expanding compared to balloon-expandable transfemoral TAVR having significantly lower in-hospital mortality (2.41% vs. 5.17%; <jats:italic>p<\/jats:italic>\u2009=\u20090.039). After risk adjustment, balloon-expandable as well as self-expanding transfemoral TAVR were associated with a significantly lower mortality vs. SAVR (balloon-expandable: risk adjusted OR\u2009=\u20090.50 [95% CI 0.27; 0.94], <jats:italic>p<\/jats:italic>\u2009=\u20090.031; self-expanding: OR\u2009=\u20090.20 [0.10; 0.41], <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001). Furthermore, the observed in-hospital outcomes of stroke, major bleeding, delirium, and mechanical ventilation &amp;gt;48\u2005h were significantly in favor of TAVR. In addition, TAVR showed a significantly shorter length of hospital stay compared to SAVR (transapical: risk adjusted Coefficient\u2009=\u2009\u22124.75d [\u22127.05d; \u22122.46d], <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001; balloon-expandable: Coefficient\u2009=\u2009\u22126.88d [\u22129.06d; \u22124.69d], <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001; self-expanding: Coefficient\u2009=\u2009\u22127.22 [\u22128.95; \u22125.49], <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>TAVR is a viable alternative to SAVR in the treatment of pure aortic regurgitation for selected patients, showing overall low in-hospital mortality and complication rates, especially with regard to self-expanding transfemoral TAVR.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2023.1091983","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T04:30:27Z","timestamp":1683001827000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Treatment of pure aortic regurgitation using surgical or transcatheter aortic valve replacement between 2018 and 2020 in Germany"],"prefix":"10.3389","volume":"10","author":[{"given":"Vera","family":"Oettinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Hilgendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Stachon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Zehender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Westermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Kaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"von zur M\u00fchlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.acvd.2012.01.005","article-title":"Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey","volume":"105","author":"Cribier","year":"2012","journal-title":"Arch Cardiovasc Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1056\/NEJMoa1500893","article-title":"Effect of availability of transcatheter aortic-valve replacement on clinical practice","volume":"373","author":"Rein\u00f6hl","year":"2015","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s00059-016-4461-1","article-title":"Temporal trends in transcatheter and surgical aortic valve replacement: an analysis of aortic valve replacements in Germany during 2012-2014","volume":"42","author":"Gaede","year":"2017","journal-title":"Herz"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/ccd.28361","article-title":"Nationwide outcomes of aortic valve replacement for pure aortic regurgitation in Germany 2008\u20132015","volume":"95","author":"Stachon","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e011504","DOI":"10.1161\/JAHA.118.011504","article-title":"Risk-Adjusted comparison of in-hospital outcomes of transcatheter and surgical aortic valve replacement","volume":"8","author":"Stachon","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.athoracsur.2018.10.004","article-title":"The society of thoracic surgeons adult cardiac surgery database: 2019 update on outcomes and quality","volume":"107","author":"D'Agostino","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS)","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1161\/CIR.0000000000000923","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/j.jcin.2016.07.035","article-title":"Transcatheter aortic valve replacement","volume":"9","author":"Rein\u00f6hl","year":"2016","journal-title":"JACC: Cardiovasc Intervent"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-20336-y","article-title":"Hospital intervention volume affects outcomes of emergency transcatheter aortic valve implantations in Germany","volume":"12","author":"Oettinger","year":"2022","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S1010-7940(99)00134-7","article-title":"European System for cardiac operative risk evaluation (Euro SCORE)","volume":"16","author":"Nashef","year":"1999","journal-title":"Eur J Cardiothorac Surg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/ije\/dyu029","article-title":"Estimating predicted probabilities from logistic regression: different methods correspond to different target populations","volume":"43","author":"Muller","year":"2014","journal-title":"Int J Epidemiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpubh.2020.594117","article-title":"Reduced rate of inpatient hospital admissions in 18 German university hospitals during the COVID-19 lockdown","volume":"8","author":"Kapsner","year":"2021","journal-title":"Front Public Health"},{"key":"B15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s00392-022-02102-2","article-title":"COVID-19 pandemic affects STEMI numbers and in-hospital mortality: results of a nationwide analysis in Germany","volume":"112","author":"Oettinger","year":"2023","journal-title":"Clin Res Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijcard.2017.02.138","article-title":"Learning curves among all patients undergoing transcatheter aortic valve implantation in Germany: a retrospective observational study","volume":"235","author":"Kaier","year":"2017","journal-title":"Int J Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1161\/CIRCULATIONAHA.114.012525","article-title":"Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy","volume":"131","author":"Blackstone","year":"2015","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.amjcard.2015.10.036","article-title":"Immediate and intermediate outcome after transapical versus transfemoral transcatheter aortic valve replacement","volume":"117","author":"Biancari","year":"2016","journal-title":"Am J Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.ijcard.2016.11.104","article-title":"Evaluation of current practices in transcatheter aortic valve implantation: the WRITTEN (WoRldwIde TAVI ExperieNce) survey","volume":"228","author":"Cerrato","year":"2017","journal-title":"Int J Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"AB40","DOI":"10.4244\/EIJ-D-18-00552","article-title":"Current state of alternative access for transcatheter aortic valve implantation","volume":"14","author":"Lanz","year":"2018","journal-title":"EuroIntervention"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.jtcvs.2020.02.078","article-title":"Transapical aortic valve replacement versus surgical aortic valve replacement: a subgroup analyses for at-risk populations","volume":"162","author":"Stachon","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","article-title":"2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European society of cardiology (ESC). endorsed by: european association for cardio-thoracic surgery (EACTS), the European association of nuclear medicine (EANM)","volume":"36","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1093\/eurheartj\/ehu281","article-title":"2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European society of cardiology (ESC)","volume":"35","author":"Erbel","year":"2014","journal-title":"Eur Heart J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"E153","DOI":"10.1002\/ccd.29379","article-title":"Transcatheter aortic valve replacement in aortic regurgitation: the US experience","volume":"98","author":"Arora","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"B25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/ccd.29189","article-title":"Short-term outcomes of transcatheter aortic valve replacement for pure native aortic regurgitation in the United States","volume":"97","author":"Isogai","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s00392-021-01928-6","article-title":"In-hospital outcomes of self-expanding and balloon-expandable transcatheter heart valves in Germany","volume":"110","author":"Stachon","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1093\/eurheartj\/ehaa036","article-title":"Comparison of newer generation self-expandable vs. Balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial","volume":"41","author":"Thiele","year":"2020","journal-title":"Eur Heart J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jcin.2019.12.026","article-title":"5-Year Outcomes after TAVR with balloon-expandable versus self-expanding valves: results from the CHOICE randomized clinical trial","volume":"13","author":"Abdel-Wahab","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"B29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.amjcard.2022.02.028","article-title":"Outcomes in valve-in-valve transcatheter aortic valve implantation","volume":"172","author":"van Nieuwkerk","year":"2022","journal-title":"Am J Cardiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1136\/heartjnl-2019-316058","article-title":"Outcomes of transcatheter aortic valve implantations in high-volume or low-volume centres in Germany","volume":"106","author":"Oettinger","year":"2020","journal-title":"Heart"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e020204","DOI":"10.1136\/bmjopen-2017-020204","article-title":"Volume-outcome relationship in transcatheter aortic valve implantations in Germany 2008-2014: a secondary data analysis of electronic health records","volume":"8","author":"Kaier","year":"2018","journal-title":"BMJ Open"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/ehf2.13202","article-title":"Temporal trends in incidence, causes, use of mechanical circulatory support and mortality in cardiogenic shock","volume":"8","author":"Schrage","year":"2021","journal-title":"ESC Heart Fail"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1007\/s00392-020-01612-1","article-title":"Temporal trends in incidence and outcome of acute coronary syndrome","volume":"109","author":"Neumann","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/eurheartj\/ehu043","article-title":"German Nationwide data on current trends and management of acute myocardial infarction: discrepancies between trials and real-life","volume":"35","author":"Freisinger","year":"2014","journal-title":"Eur Heart J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/eurheartj\/ehaa799","article-title":"Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"42","author":"G\u00e9n\u00e9reux","year":"2021","journal-title":"Eur Heart J"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1091983\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T04:30:30Z","timestamp":1683001830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1091983\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":35,"alternative-id":["10.3389\/fcvm.2023.1091983"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1091983","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]},"article-number":"1091983"}}